Sex differences in the developmental origins of hypertension and cardiorenal disease

Jeffrey S. Gilbert1, Mark J. Nijland2
1Department of Physiology and Pharmacology, University of Minnesota Medical School-Duluth, Duluth, MN 55812, USA.
2UT Health Science Center at San Antonio

Tóm tắt

The “developmental origins of health and disease” (DOHAD) hypothesis derives from clinical observations, indicating long-term health consequences for persons of low birth weight. There is growing evidence, primarily from animal studies, that supports the idea that processes put in motion during development that contribute to DOHAD do not necessarily reflect as significantly compromised growth and altered birth weight. Throughout the body of work investigating the DOHAD hypothesis, several themes have emerged; the importance of the placenta, the presence of critical periods of vulnerability, the involvement of the kidney in programmed hypertension, the presence of sex differences in the progression and development of adult diseases. Despite compelling findings in recent studies, much remains unclear regarding the impact of biological sex in the progression of human diseases, in general, and in the mechanisms underlying developmentally programmed responses, in particular. Although the contribution of biological sex to DOHAD is increasingly recognized, it also appears that it may exert distinctly different influences during fetal and adult life. The mechanisms by which biological sex contributes to these processes remains nebulous at present; nevertheless, several intriguing mechanistic candidates have been proposed ranging from differences in the amounts of sex hormones (e.g., estrogens, androgens) to recently described sexual dimorphism in the transcriptome of a variety of mammalian tissues. Recognizing the influences of biological sex or sex hormones on DOHAD uniquely situates research in this area to provide significant insights into the development and progression of many diseases, recent examples of which are the subject of this review.

Từ khóa


Tài liệu tham khảo

10.1210/me.2003-0138

10.1152/ajprenal.00285.2007

10.1161/01.HYP.0000053448.95913.3D

10.1113/jphysiol.2005.084947

10.1002/mrd.1080320312

10.1136/hrt.69.3.195

10.1530/ror.0.0020105

10.1152/ajpregu.00558.2006

10.1152/ajpendo.00004.2001

10.1113/jphysiol.2007.141580

10.1093/HUMREP/11.3.621

10.1038/321209a0

10.1542/peds.2004-1808

Bridges JP, Gilbert JS, Colson D, Dukes M, Babcock SA, Ryan MJ, Granger JP.Soluble Flt-1 induces hypertension and vascular dysfunction in pregnant rats.FASEB J22: 969, 2008.

10.1017/S0007114507352392

10.1161/01.HYP.25.3.305

10.1067/mpd.2000.105129

10.1146/annurev.genom.6.080604.162350

Cox LA, Glenn J, Schiabritz-Loutsevitch NE, Nathanielsz PW, Nijland MJ.Sex effects of maternal nutrient restriction (MNR) on renal transcriptome expression in the 0.9 gestation (G) fetal baboon.Reprod Sci15: 120A, 2008.

10.1113/jphysiol.2006.106872

10.1093/oxfordjournals.humrep.a136581

10.1161/01.HYP.0000052949.85257.8E

10.1016/S0008-6363(01)00527-2

10.1016/j.ydbio.2003.12.018

10.1161/HYPERTENSIONAHA.107.100982

10.1038/nrg2167

10.1152/ajpendo.00390.2006

Gilbert JS, Cox L, Babcock SA, Shade R, Nathanielsz PW, Nijland MJ.Gender-specific effects of moderate maternal nutrient restriction (NR) in the first half of pregnancy on fetal renal renin-angiotensin system (RAS).J Soc Gynecol Investig13: 207A, 2006.

10.1586/14779072.4.2.227

10.1203/01.pdr.0000250208.09874.91

10.1096/fj.01-0764fje

10.1113/jphysiol.2005.084202

10.1186/1477-7827-3-27

10.1161/HYPERTENSIONAHA.107.096594

10.1093/jn/137.1.259S

10.1016/j.genm.2008.03.012

10.1152/ajpregu.00725.2006

Gubhaju L, Nathanielsz PW, Nyengaard JR, Nijland MJ, Black MJ.Effects of a thirty percent global reduction in maternal nutrient intake on development of the fetal baboon kidney at term.Early Hum Dev83: S166–S167, 2007.

10.1002/(SICI)1098-2795(200002)55:2<146::AID-MRD3>3.0.CO;2-F

10.1053/j.ajkd.2007.09.013

10.1016/0002-9378(89)90924-1

Haris RC.Cyclooxygenase-2 in the Kidney.J Am Soc Nephrol11: 2387–2394, 2000.

10.1095/biolreprod.104.035675

10.1203/00006450-200208000-00020

10.1016/S1046-2023(02)00072-5

10.1152/ajpregu.00442.2006

10.1152/advan.00099.2006

10.1093/jn/128.7.1204

10.1093/eurheartj/ehn292

10.1161/01.HYP.0000257196.13485.9b

10.1007/s10545-006-0299-7

10.1053/j.ajkd.2007.06.015

10.1111/j.0009-9163.2004.00236.x

10.1152/ajpregu.00354.2004

10.1161/01.HYP.0000047511.97879.FC

10.1007/s004670000473

10.1093/hmg/7.12.1967

10.1093/hmg/9.18.2767

Kwong WY, Wild AE, Roberts P, Willis AC, Fleming TP.Maternal undernutrition during the preimplantation period of rat development causes blastocyst abnormalities and programming of postnatal hypertension.Development127: 4195–4202, 2000.

10.1001/archinte.160.10.1472

10.1016/0300-9629(96)00018-7

10.1042/cs0930423

10.1079/PNS2001111

10.1136/bmj.315.7106.449

10.1073/pnas.171305398

10.1161/01.CIR.0000145165.80130.B5

10.1089/ars.2005.7.1285

Li S, Chen SC, Shlipak M, Bakris G, McCullough PA, Sowers J, Stevens L, Jurkovitz C, McFarlane S, Norris K, Vassalotti J, Klag MJ, Brown WW, Narva A, Calhoun D, Johnson B, Obialo C, Whaley-Connell A, Becker B, Collins AJ.Low birth weight is associated with chronic kidney disease only in men.Kidney Int73: 637–642, 2007.

Lillycrop KA, Phillips ES, Torrens C, Hanson MA, Jackson AA, Burdge GC.Feeding pregnant rats a protein-restricted diet persistently alters the methylation of specific cytosines in the hepatic PPAR alpha promoter of the offspring.Br J Nutr100: 278–282, 2008.

10.1017/S000711450769196X

10.1093/jn/135.6.1382

10.1152/ajpregu.00191.2007

10.1152/ajprenal.00066.2007

Lu F, Bytautiene E, Tamayo E, Gamble P, Anderson GD, Hankins GD, Longo M, Saade GR.Gender-specific effect of overexpression of sFlt-1 in pregnant mice on fetal programming of blood pressure in the offspring later in life.Am J Obstet Gynecol197: 418–5, 2007.

Lu F, Longo M, Tamayo E, Maner W, Al-Hendy A, Anderson GD, Hankins GDV, Saade GR.The effect of over-expression of sFlt-1 on blood pressure and the occurrence of other manifestations of preeclampsia in unrestrained conscious pregnant mice [Online].Am J Obstet Gynecol196: 396, 2007.

10.1038/sj.ki.5002175

10.1161/01.CIR.90.2.928

10.1093/jn/133.3.941S

10.1152/physrev.00053.2003

10.1079/BJN20031029

10.1152/ajpgi.00169.2004

10.1161/01.HYP.0000188702.96256.46

10.1152/ajpregu.00523.2002

10.1046/j.1523-1755.1999.00260.x

10.1152/ajprenal.00383.2002

10.1096/fj.05-3911rev

10.1159/000049033

10.1677/JOE-07-0327

10.1053/j.ackd.2008.01.001

10.1161/HYPERTENSIONAHA.107.091785

10.1152/ajpheart.00718.2006

10.1161/01.HYP.0000049763.51269.51

10.1111/j.1469-7793.2001.0141m.x

10.1016/S0960-9822(95)00207-7

10.1016/0002-9378(84)90255-2

10.1093/molehr/8.10.923

10.1152/ajpregu.00887.2006

10.1161/01.ATV.0000186185.13977.94

10.1161/01.HYP.31.1.435

10.1161/01.HYP.37.5.1199

10.1111/j.1558-5646.1984.tb00346.x

10.1016/j.devcel.2004.05.005

10.1016/j.tig.2005.03.005

10.1152/ajpregu.00424.2006

10.1161/HYPERTENSIONAHA.107.087957

10.1159/000188433

10.1161/HYPERTENSIONAHA.107.100750

10.1161/HYPERTENSIONAHA.107.101477

10.1053/jarr.2003.50006

10.1161/01.HYP.32.1.59

10.1023/A:1007011807383

10.1016/S1550-8579(08)80003-4

10.1016/j.cardiores.2004.01.020

10.1073/pnas.0707258104

10.1097/00005237-199812000-00005

10.1073/pnas.0508035103

10.1152/ajpregu.00429.2007

10.1152/ajpregu.00864.2007

10.1136/bmj.326.7401.1245

10.1093/molehr/7.2.147

10.1113/jphysiol.2002.018879

10.1016/S0092-8674(00)81444-0

10.1210/en.2002-0190

10.1073/pnas.94.14.7239

10.1002/mrd.1080350204

10.1097/00004872-200412000-00011

10.1146/annurev.nutr.27.061406.093705

10.1016/0895-7061(95)00216-2

10.1161/01.CIR.0000089505.34741.E5

10.1210/me.2004-0129

10.1152/ajpregu.1999.276.4.R974

10.1203/00006450-200104000-00005

10.1152/ajpregu.1998.275.5.R1593

10.1152/ajpregu.00037.2003

10.1095/biolreprod66.1.127

10.1161/HYPERTENSIONAHA.107.091603

10.1210/en.2005-0748

10.1002/mrd.1080360405

10.1152/ajpcell.00296.2004

10.1093/oxfordjournals.aje.a116817

10.1016/S0168-9525(01)02446-5